Search research articles
Contact Us
Filters
Showing results (171-180 of 464) with videos related to
Page
of 47
Sort By:
Journal of Chemical Information and Modeling
|
June 18, 2013
Modeling compound-target interaction network of traditional Chinese medicines for type II diabetes mellitus: insight for polypharmacology and drug design
Sheng Tian, Youyong Li, Dan Li, et al.
Drug Discovery Today
|
March 8, 2013
Current developments of macrophage migration inhibitory factor (MIF) inhibitors
Lei Xu, Youyong Li, Huiyong Sun, et al.
Journal of Cheminformatics
|
November 28, 2012
Drug-likeness analysis of traditional Chinese medicines: 1. property distributions of drug-like compounds, non-drug-like compounds and natural compounds from traditional Chinese medicines
Mingyun Shen, Sheng Tian, Youyong Li, et al.
Medicinal Research Reviews
|
December 10, 2020
Targeting phosphatidylinositol 3-kinase gamma (PI3Kγ): Discovery and development of its selective inhibitors
Jingyu Zhu, Kan Li, Li Yu, et al.
Chemical Research in Toxicology
|
December 16, 2014
Absorption, Distribution, Metabolism, Excretion, and Toxicity Evaluation in Drug Discovery. 14. Prediction of Human Pregnane X Receptor Activators by Using Naive Bayesian Classification Technique
Huali Shi, Sheng Tian, Youyong Li, et al.
Briefings in Bioinformatics
|
November 30, 2025
Improving the predictive performance of binding affinities and poses for protein-cyclic peptide complexes through fine-tuned MM/PBSA(GBSA)-based methods
Huifeng Zhao, Jianxiang Huang, Gaoqi Weng, et al.
Drug Discovery Today
|
January 22, 2025
Artificial intelligence in peptide-based drug design
Silong Zhai, Tiantao Liu, Shaolong Lin, et al.
Nature Communications
|
November 7, 2024
Integration of molecular coarse-grained model into geometric representation learning framework for protein-protein complex property prediction
Yang Yue, Shu Li, Yihua Cheng, et al.
Drug Discovery Today
|
September 19, 2021
Opportunities for overcoming tuberculosis: Emerging targets and their inhibitors
Liu Yang, Xueping Hu, Xin Chai, et al.
Molecular Cancer Therapeutics
|
May 18, 2012
New use for an old drug: inhibiting ABCG2 with sorafenib
Yinxiang Wei, Yuanfang Ma, Qing Zhao, et al.
Page
of 47
Search research articles
Search
Showing results (171-180 of 464) with videos related to
Sort By:
Page
of 47
Journal of Chemical Information and Modeling
|
June 18, 2013
Modeling compound-target interaction network of traditional Chinese medicines for type II diabetes mellitus: insight for polypharmacology and drug design
Sheng Tian, Youyong Li, Dan Li, et al.
Drug Discovery Today
|
March 8, 2013
Current developments of macrophage migration inhibitory factor (MIF) inhibitors
Lei Xu, Youyong Li, Huiyong Sun, et al.
Journal of Cheminformatics
|
November 28, 2012
Drug-likeness analysis of traditional Chinese medicines: 1. property distributions of drug-like compounds, non-drug-like compounds and natural compounds from traditional Chinese medicines
Mingyun Shen, Sheng Tian, Youyong Li, et al.
Medicinal Research Reviews
|
December 10, 2020
Targeting phosphatidylinositol 3-kinase gamma (PI3Kγ): Discovery and development of its selective inhibitors
Jingyu Zhu, Kan Li, Li Yu, et al.
Chemical Research in Toxicology
|
December 16, 2014
Absorption, Distribution, Metabolism, Excretion, and Toxicity Evaluation in Drug Discovery. 14. Prediction of Human Pregnane X Receptor Activators by Using Naive Bayesian Classification Technique
Huali Shi, Sheng Tian, Youyong Li, et al.
Briefings in Bioinformatics
|
November 30, 2025
Improving the predictive performance of binding affinities and poses for protein-cyclic peptide complexes through fine-tuned MM/PBSA(GBSA)-based methods
Huifeng Zhao, Jianxiang Huang, Gaoqi Weng, et al.
Drug Discovery Today
|
January 22, 2025
Artificial intelligence in peptide-based drug design
Silong Zhai, Tiantao Liu, Shaolong Lin, et al.
Nature Communications
|
November 7, 2024
Integration of molecular coarse-grained model into geometric representation learning framework for protein-protein complex property prediction
Yang Yue, Shu Li, Yihua Cheng, et al.
Drug Discovery Today
|
September 19, 2021
Opportunities for overcoming tuberculosis: Emerging targets and their inhibitors
Liu Yang, Xueping Hu, Xin Chai, et al.
Molecular Cancer Therapeutics
|
May 18, 2012
New use for an old drug: inhibiting ABCG2 with sorafenib
Yinxiang Wei, Yuanfang Ma, Qing Zhao, et al.
Page
of 47